May 28, 2021
MIMETAS Opens Phenotypic Screening Center
LEIDEN, the Netherlands, May 27, 2021 / B3C newswire / -- MIMETAS, the global leader…
May 26, 2021
BioFactura Announces Initiation of Phase I Study of BFI-751, a Stelara® (ustekinumab) Biosimilar | Business Wire
FREDERICK, Md.--(BUSINESS WIRE)--BioFactura, a leading developer of high-value biosimilar and biodefense drugs using its patented…
May 26, 2021
NIH spinout raises millions to attack drug-resistant cancers with RNA. It has big plans. · BioBuzz
A local biotech has secured millions of dollars in new investments to take its RNA therapies for…
May 25, 2021
miRecule Inc. closes $5.7 M to Create Breakthrough RNA Therapies for Cancer and Muscular Dystrophy
Gaithersburg, MD. (May ____ 2021) miRecule, Inc. (“miRecule”), an emerging biotech company focused on the…
May 24, 2021
NIH spinout fighting cancer with RNA therapeutics raises millions – Washington Business Journal
The startup is developing therapeutics for drug-resistant cancers — and applying its technology to other…
